151 related articles for article (PubMed ID: 38288105)
1. Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma.
Khalid KM; Ratnayake WS; Apostolatos CA; Acevedo-Duncan M
Front Oncol; 2023; 13():1213715. PubMed ID: 38288105
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors.
Ratnayake WS; Apostolatos CA; Apostolatos AH; Schutte RJ; Huynh MA; Ostrov DA; Acevedo-Duncan M
Cell Adh Migr; 2018; 12(5):447-463. PubMed ID: 29781749
[TBL] [Abstract][Full Text] [Related]
3. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS; Apostolatos AH; Ostrov DA; Acevedo-Duncan M
Int J Oncol; 2017 Nov; 51(5):1370-1382. PubMed ID: 29048609
[TBL] [Abstract][Full Text] [Related]
4. Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway.
BommaReddy RR; Patel R; Smalley T; Acevedo-Duncan M
Onco Targets Ther; 2020; 13():1661-1676. PubMed ID: 32158232
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade.
Islam SMA; Patel R; Acevedo-Duncan M
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):650-664. PubMed ID: 29408512
[TBL] [Abstract][Full Text] [Related]
6. A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma.
Pillai P; Desai S; Patel R; Sajan M; Farese R; Ostrov D; Acevedo-Duncan M
Int J Biochem Cell Biol; 2011 May; 43(5):784-94. PubMed ID: 21315177
[TBL] [Abstract][Full Text] [Related]
7. The interruption of atypical PKC signaling and Temozolomide combination therapy against glioblastoma.
Dey A; Islam SMA; Patel R; Acevedo-Duncan M
Cell Signal; 2021 Jan; 77():109819. PubMed ID: 33147518
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.
Breedy S; Ratnayake WS; Lajmi L; Hill R; Acevedo-Duncan M
Front Oncol; 2023; 13():1051516. PubMed ID: 36776326
[TBL] [Abstract][Full Text] [Related]
9. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells.
Wooten MW; Seibenhener ML; Neidigh KB; Vandenplas ML
Mol Cell Biol; 2000 Jul; 20(13):4494-504. PubMed ID: 10848576
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous inhibition of atypical protein kinase‑C and mTOR impedes bladder cancer cell progression.
Patel R; Islam SA; Bommareddy RR; Smalley T; Acevedo-Duncan M
Int J Oncol; 2020 Jun; 56(6):1373-1386. PubMed ID: 32236625
[TBL] [Abstract][Full Text] [Related]
11. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Sajan MP; Nimal S; Mastorides S; Acevedo-Duncan M; Kahn CR; Fields AP; Braun U; Leitges M; Farese RV
Metabolism; 2012 Apr; 61(4):459-69. PubMed ID: 22225955
[TBL] [Abstract][Full Text] [Related]
12. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
[TBL] [Abstract][Full Text] [Related]
13. Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic.
Apostolatos AH; Apostolatos CA; Ratnayake WS; Neuger A; Sansil S; Bourgeois M; Acevedo-Duncan M
Anticancer Drugs; 2019 Jan; 30(1):65-71. PubMed ID: 30204596
[TBL] [Abstract][Full Text] [Related]
14. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
15. The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression.
Smalley T; Metcalf R; Patel R; Islam SMA; Bommareddy RR; Acevedo-Duncan M
Front Oncol; 2020; 10():209. PubMed ID: 32175276
[TBL] [Abstract][Full Text] [Related]
16. Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion.
Ratnayake WS; Apostolatos CA; Breedy S; Dennison CL; Hill R; Acevedo-Duncan M
Cell Adh Migr; 2021 Dec; 15(1):37-57. PubMed ID: 33525953
[TBL] [Abstract][Full Text] [Related]
17. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.
Musi E; Ambrosini G; de Stanchina E; Schwartz GK
Mol Cancer Ther; 2014 May; 13(5):1044-53. PubMed ID: 24563540
[TBL] [Abstract][Full Text] [Related]
18. Effect of AKT silence on malignant biological behavior of renal cell carcinoma cells.
Li Z; Nong D; Li B; Wang H; Li C; Chen Z; Li X; Huang G; Lin J; Hao N; Li W
BMC Urol; 2022 Aug; 22(1):129. PubMed ID: 35996134
[TBL] [Abstract][Full Text] [Related]
19. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
20. Differential signalling of purinoceptors in HeLa cells through the extracellular signal-regulated kinase and protein kinase C pathways.
Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
J Cell Physiol; 2004 Sep; 200(3):428-39. PubMed ID: 15254971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
